Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-11-18

Clinical Trial Update: EFfects of Y-6 SUblingual Tablets foR PaTients With AcUte Ischemic StRokE (FUTURE) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for Y-6 SUblingual Tablets in acute ischemic stroke with large vessel occlusion; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Y-6 Sublingual Tablets

Snippet

Sponsor: Beijing Tiantan Hospital | Conditions: Acute Ischemic Stroke, Large Vessel Occlusion | Phase 2 | Status: UNKNOWN